Clinical significance and condition	Chrpos	Variation Name	AA Chg
Uncertain significance: Acromicric Dysplasia ; Weill-Marchesani Syndrome 2 ; Mccune-Albright Syndrome ; Geleophysic Dysplasia 2 ; Ectopia Lentis 1, Isolated, Autosomal Dominant ; Stiff Skin Syndrome ; Marfanoid-Progeroid-Lipodystrophy Syndrome Likely benign: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4 ; Marfan Syndrome	48,444,640(-)	NM_000138.5(FBN1):c.5938G>C (p.Glu1980Gln)	E1980Q
Uncertain significance: Acromicric Dysplasia ; Weill-Marchesani Syndrome 2 ; Mccune-Albright Syndrome ; Geleophysic Dysplasia 2 ; Ectopia Lentis 1, Isolated, Autosomal Dominant ; Stiff Skin Syndrome ; Marfanoid-Progeroid-Lipodystrophy Syndrome Likely benign: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4 ; Marfan Syndrome	48,446,777(-)	NM_000138.5(FBN1):c.5717G>A (p.Arg1906Gln)	R1906Q
Uncertain significance: not specified ; not provided Likely benign: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4 ; Marfan Syndrome	48,425,838(-)	NM_000138.5(FBN1):c.7231G>A (p.Asp2411Asn)	D2411N
Uncertain significance: Acromicric Dysplasia ; Weill-Marchesani Syndrome 2 ; Mccune-Albright Syndrome ; Geleophysic Dysplasia 2 ; Ectopia Lentis 1, Isolated, Autosomal Dominant ; Stiff Skin Syndrome ; Marfanoid-Progeroid-Lipodystrophy Syndrome Likely benign: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4 ; Marfan Syndrome	48,446,741(-)	NM_000138.5(FBN1):c.5753A>G (p.His1918Arg)	H1918R
Uncertain significance: Acromicric Dysplasia ; Weill-Marchesani Syndrome 2 ; Weill-Marchesani Syndrome ; Weill-Marchesani Syndrome 1 ; Mccune-Albright Syndrome ; Geleophysic Dysplasia 2 ; Ectopia Lentis 1, Isolated, Autosomal Dominant ; Stiff Skin Syndrome ; Marfanoid-Progeroid-Lipodystrophy Syndrome ; Lymphoplasmacytic Lymphoma ; Marfan Syndrome ; not provided Benign: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4	48,425,828(-)	NM_000138.5(FBN1):c.7241G>A (p.Arg2414Gln)	R2414Q
Uncertain significance: Marfan Syndrome ; not provided Likely benign: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4	48,412,714(-)	NM_000138.5(FBN1):c.8081G>A (p.Arg2694Gln)	R2694Q
Uncertain significance: Acromicric Dysplasia ; Weill-Marchesani Syndrome 2 ; Mccune-Albright Syndrome ; Geleophysic Dysplasia 2 ; Ectopia Lentis 1, Isolated, Autosomal Dominant ; Stiff Skin Syndrome ; Marfanoid-Progeroid-Lipodystrophy Syndrome ; Marfan Syndrome Likely benign: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4	48,644,701(-)	NM_000138.5(FBN1):c.69T>C (p.His23=)	
Uncertain significance: Acromicric Dysplasia ; Weill-Marchesani Syndrome 2 ; Mccune-Albright Syndrome ; Geleophysic Dysplasia 2 ; Ectopia Lentis 1, Isolated, Autosomal Dominant ; Stiff Skin Syndrome ; Marfanoid-Progeroid-Lipodystrophy Syndrome ; Marfan Syndrome Likely benign: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4	48,437,922(-)	NM_000138.5(FBN1):c.6164-5T>C	
Uncertain significance: not provided Likely benign: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4 ; Marfan Syndrome	48,467,949(-)	NM_000138.5(FBN1):c.4736C>T (p.Ala1579Val)	A1579V
Uncertain significance: Marfan Syndrome Likely benign: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4	48,430,764(-)	NM_000138.5(FBN1):c.6778G>A (p.Glu2260Lys)	E2260K
Uncertain significance: not specified Likely benign: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4 ; Marfan Syndrome	48,425,742(-)	NM_000138.5(FBN1):c.7327G>A (p.Val2443Ile)	V2443I
Uncertain significance: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4 Likely benign: Marfan Syndrome	48,537,775(-)	NM_000138.5(FBN1):c.572G>T (p.Ser191Ile)	S191I
Uncertain significance: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4 ; not provided Likely benign: Marfan Syndrome	48,412,697(-)	NM_000138.5(FBN1):c.8098C>T (p.Pro2700Ser)	P2700S
Uncertain significance: Marfan Syndrome Likely benign: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4	48,492,529(-)	NM_000138.5(FBN1):c.2786C>G (p.Thr929Ser)	T929S
Uncertain significance: Acromicric Dysplasia ; Weill-Marchesani Syndrome 2 ; Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Mccune-Albright Syndrome ; Geleophysic Dysplasia 2 ; Ectopia Lentis 1, Isolated, Autosomal Dominant ; Stiff Skin Syndrome ; Aortic Aneurysm, Familial Thoracic 4 ; Hirschsprung Disease 1 ; Marfanoid-Progeroid-Lipodystrophy Syndrome ; not provided ; not specified Likely benign: Marfan Syndrome	48,513,590(-)	NM_000138.5(FBN1):c.1547G>A (p.Arg516Gln)	R516Q
Pathogenic: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4 ; Marfan Syndrome	48,463,211(-)	NM_000138.5(FBN1):c.5095T>A (p.Tyr1699Asn)	Y1699N
Pathogenic: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4 ; Marfan Syndrome	48,613,088(-)	NM_000138.5(FBN1):c.169A>G (p.Asn57Asp)	N57D
Pathogenic: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4 ; Marfan Syndrome	48,463,132(-)	NM_000138.5(FBN1):c.5174T>A (p.Ile1725Asn)	I1725N
Pathogenic: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4 ; Marfan Syndrome Likely pathogenic: not provided	48,505,102(-)	NM_000138.5(FBN1):c.1883G>A (p.Cys628Tyr)	C628Y
Pathogenic: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4 ; Marfan Syndrome	48,425,412(-)	NM_000138.5(FBN1):c.7409_7410delinsAT (p.Cys2470Tyr)	C2470Y
Pathogenic: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,189,528(-)	NM_000088.4(COL1A1):c.2678G>C (p.Gly893Ala)	G893A
Pathogenic: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,186,885(-)	NM_000088.4(COL1A1):c.3569G>A (p.Gly1190Asp)	G1190D
Pathogenic: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,196,661(-)	NM_000088.4(COL1A1):c.814G>A (p.Gly272Ser)	G272S
Pathogenic: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder ; not provided Likely pathogenic: Osteogenesis Imperfecta, Type Iii	50,191,814(-)	NM_000088.4(COL1A1):c.2101G>A (p.Gly701Ser)	G701S
Pathogenic: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,195,976(-)	NM_000088.4(COL1A1):c.1003G>A (p.Gly335Ser)	G335S
Pathogenic: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder Pathogenic/Likely pathogenic: not provided Likely pathogenic: Osteogenesis Imperfecta, Type Ii	50,196,181(-)	NM_000088.4(COL1A1):c.976G>C (p.Gly326Arg)	G326R
Likely pathogenic: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4 Conflicting interpretations of pathogenicity: Osteogenesis Imperfecta, Type I Uncertain significance: Caffey Disease ; Ehlers-Danlos Syndrome, Arthrochalasia Type ; Brittle Bone Disorder ; Ehlers-Danlos Syndrome, Arthrochalasia Type, 1 ; Ehlers-Danlos Syndrome ; not provided ; Cardiovascular phenotype ; COL1A1-related disorder Likely benign: not specified	50,195,937(-)	NM_000088.4(COL1A1):c.1042G>A (p.Ala348Thr)	A348T
Likely pathogenic: Brittle Bone Disorder	50,195,296(-)	NM_000088.4(COL1A1):c.1235C>G (p.Pro412Arg)	P412R
Likely pathogenic: Brittle Bone Disorder	50,194,419(-)	NM_000088.4(COL1A1):c.1544G>C (p.Gly515Ala)	G515A
Likely pathogenic: Brittle Bone Disorder Uncertain significance: Ehlers-Danlos Syndrome, Arthrochalasia Type ; Ehlers-Danlos Syndrome, Arthrochalasia Type, 1 ; Cardiovascular phenotype Benign: Osteogenesis Imperfecta, Type I	50,189,878(-)	NM_000088.4(COL1A1):c.2594G>A (p.Arg865His)	R865H
Likely pathogenic: Brittle Bone Disorder	50,189,208(-)	NM_000088.4(COL1A1):c.2897A>G (p.Gln966Arg)	Q966R
Likely pathogenic: Familial Thoracic Aortic Aneurysm And Aortic Dissection ; Aortic Aneurysm, Familial Thoracic 4 Conflicting interpretations of pathogenicity: not provided Uncertain significance: Caffey Disease ; Ehlers-Danlos Syndrome ; Cardiovascular phenotype Likely benign: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder ; Connective Tissue Disease ; not specified Benign: Ehlers-Danlos Syndrome, Arthrochalasia Type ; Ehlers-Danlos Syndrome, Arthrochalasia Type, 1	50,189,173(-)	NM_000088.4(COL1A1):c.2932C>T (p.Pro978Ser)	P978S
Uncertain significance: Ehlers-Danlos Syndrome, Arthrochalasia Type ; Ehlers-Danlos Syndrome, Arthrochalasia Type, 1 Likely benign: not provided ; Cardiovascular phenotype Benign: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,199,918(-)	NM_000088.4(COL1A1):c.133C>G (p.Leu45Val)	L45V
Uncertain significance: not provided	50,185,525(-)	NM_000088.4(COL1A1):c.4372G>C (p.Val1458Leu)	V1458L
Uncertain significance: not provided ; Cardiovascular phenotype Likely benign: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,190,041(-)	NM_000088.4(COL1A1):c.2519C>T (p.Pro840Leu)	P840L
Uncertain significance: not provided Likely benign: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,194,753(-)	NM_000088.4(COL1A1):c.1429C>G (p.Pro477Ala)	P477A
Uncertain significance: not provided	50,185,623(-)	NM_000088.4(COL1A1):c.4274C>T (p.Thr1425Ile)	T1425I
Uncertain significance: not provided Likely benign: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,197,024(-)	NM_000088.4(COL1A1):c.790A>T (p.Met264Leu)	M264L
Uncertain significance: not provided	50,185,546(-)	NM_000088.4(COL1A1):c.4351G>T (p.Asp1451Tyr)	D1451Y
Uncertain significance: not provided	50,195,599(-)	NM_000088.4(COL1A1):c.1123C>T (p.Pro375Ser)	P375S
Uncertain significance: not provided Likely benign: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,201,453(-)	NM_000088.4(COL1A1):c.61C>T (p.His21Tyr)	H21Y
Likely benign: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,194,417(-)	NM_000088.4(COL1A1):c.1546C>T (p.Pro516Ser)	P516S
Likely benign: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,197,769(-)	NM_000088.4(COL1A1):c.659G>A (p.Arg220Gln)	R220Q
Likely benign: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,187,935(-)	NM_000088.4(COL1A1):c.3310G>A (p.Asp1104Asn)	D1104N
Likely benign: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,198,189(-)	NM_000088.4(COL1A1):c.560G>A (p.Arg187His)	R187H
Likely benign: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,189,899(-)	NM_000088.4(COL1A1):c.2573C>T (p.Ala858Val)	A858V
Likely benign: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,196,502(-)	NM_000088.4(COL1A1):c.885T>A (p.Asn295Lys)	N295K
Likely benign: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,192,836(-)	NM_000088.4(COL1A1):c.1836A>T (p.Lys612Asn)	K612N
Likely benign: Osteogenesis Imperfecta, Type I ; Brittle Bone Disorder	50,195,641(-)	NM_000088.4(COL1A1):c.1081C>G (p.Arg361Gly)	R361G
Pathogenic: Congenital Myopathy 1A ; Congenital Myopathy 1A, Autosomal Dominant, With Malignant Hyperthermia	38,469,069(+)	NM_000540.3(RYR1):c.3485C>T (p.Thr1162Ile)	T1162I
Pathogenic: Congenital Myopathy 1A ; Congenital Myopathy 1A, Autosomal Dominant, With Malignant Hyperthermia	38,586,150(+)	NM_000540.3(RYR1):c.14928C>G (p.Phe4976Leu)	F4976L
Pathogenic: RYR1-related disorder Uncertain significance: Malignant Hyperthermia ; Malignant Hyperthermia 1 ; not specified	38,529,048(+)	NM_000540.3(RYR1):c.11132C>T (p.Thr3711Met)	T3711M
Pathogenic: RYR1-related disorder Likely pathogenic: Abnormality of the musculature ; RYR1-related myopathy	38,580,054(+)	NM_000540.3(RYR1):c.14437C>T (p.His4813Tyr)	H4813Y
Pathogenic: not provided Uncertain significance: RYR1-related disorder	38,585,977(+)	NM_000540.3(RYR1):c.14843A>G (p.Gln4948Arg)	Q4948R
Pathogenic: RYR1-related disorder Pathogenic/Likely pathogenic: Malignant hyperthermia 1 Likely pathogenic: Malignant Hyperthermia	38,466,386(+)	NM_000540.3(RYR1):c.3166G>C (p.Asp1056His)	D1056H
Pathogenic: not provided Likely pathogenic: Malignant Hyperthermia	38,585,099(+)	NM_000540.3(RYR1):c.14803G>A (p.Gly4935Ser)	G4935S
Pathogenic: not provided Likely pathogenic: Malignant Hyperthermia ; Malignant Hyperthermia 1	38,499,642(+)	NM_000540.3(RYR1):c.7035C>A (p.Ser2345Arg)	S2345R
Pathogenic: not provided Uncertain significance: Malignant Hyperthermia	38,580,041(+)	NM_000540.3(RYR1):c.14424C>A (p.Phe4808Leu)	F4808L
Pathogenic: RYR1-related disorder Uncertain significance: Malignant Hyperthermia	38,499,234(+)	NM_000540.3(RYR1):c.7018T>C (p.Phe2340Leu)	F2340L
Pathogenic: RYR1-related disorder Likely pathogenic: Malignant Hyperthermia ; Malignant Hyperthermia 1 ; RYR1-related myopathy	38,499,691(+)	NM_000540.3(RYR1):c.7084G>A (p.Glu2362Lys)	E2362K
Pathogenic: Congenital Myopathy 4A ; King-Denborough Syndrome ; Congenital Myopathy 1A ; Congenital Multicore Myopathy With External Ophthalmoplegia ; Malignant Hyperthermia ; Congenital Myopathy 1A, Autosomal Dominant, With Malignant Hyperthermia ; Congenital Myopathy 4A, Autosomal Dominant ; Congenital Myopathy 1B, Autosomal Recessive ; Malignant Hyperthermia 1 ; not provided ; RYR1-related disorder ; Inborn genetic diseases Pathogenic/Likely pathogenic: Congenital myopathy 1A, autosomal dominant, with susceptibility to malignant hyperthermia ; Malignant hyperthermia 1 Drug response: desflurane response - Toxicity ; enflurane response - Toxicity ; halothane response - Toxicity ; isoflurane response - Toxicity ; methoxyflurane response - Toxicity ; sevoflurane response - Toxicity ; succinylcholine response - Toxicity	38,457,545(+)	NM_000540.3(RYR1):c.1840C>T (p.Arg614Cys)	R614C
Uncertain significance: RYR1-related disorder ; Inborn genetic diseases ; not provided	38,586,569(+)	NM_000540.3(RYR1):c.15014C>T (p.Thr5005Met)	T5005M
Uncertain significance: Congenital Multicore Myopathy With External Ophthalmoplegia ; Congenital Myopathy 1B, Autosomal Recessive ; RYR1-related disorder	38,561,154(+)	NM_000540.3(RYR1):c.12324G>C (p.Gln4108His)	Q4108H
Uncertain significance: Malignant Hyperthermia ; Malignant Hyperthermia 1 ; not provided ; RYR1-related disorder	38,496,541(+)	NM_000540.3(RYR1):c.6796G>C (p.Gly2266Arg)	G2266R
Uncertain significance: not provided	38,504,241(+)	NM_000540.3(RYR1):c.7948C>T (p.Arg2650Cys)	R2650C
Uncertain significance: Malignant Hyperthermia ; Malignant Hyperthermia 1 ; RYR1-related disorder ; not provided	38,502,508(+)	NM_000540.3(RYR1):c.7616C>G (p.Ala2539Gly)	A2539G
Uncertain significance: RYR1-related disorder	38,517,468(+)	NM_000540.3(RYR1):c.9795G>C (p.Glu3265Asp)	E3265D
Uncertain significance: RYR1-related disorder	38,502,628(+)	NM_000540.3(RYR1):c.7736T>G (p.Val2579Gly)	V2579G
Uncertain significance: RYR1-related disorder ; not provided ; Inborn genetic diseases	38,517,640(+)	NM_000540.3(RYR1):c.9967A>G (p.Ile3323Val)	I3323V
Uncertain significance: RYR1-related disorder	38,463,458(+)	NM_000540.3(RYR1):c.2613G>T (p.Glu871Asp)	E871D
Uncertain significance: Congenital Myopathy 4A ; King-Denborough Syndrome ; Congenital Myopathy 1A ; Congenital Multicore Myopathy With External Ophthalmoplegia ; Malignant Hyperthermia ; Congenital Myopathy 1A, Autosomal Dominant, With Malignant Hyperthermia ; Congenital Myopathy 4A, Autosomal Dominant ; Congenital Myopathy 1B, Autosomal Recessive ; Malignant Hyperthermia 1 ; RYR1-related disorder ; not provided ; Inborn genetic diseases	38,499,761(+)	NM_000540.3(RYR1):c.7154G>A (p.Arg2385His)	R2385H
Uncertain significance: Malignant Hyperthermia ; Malignant Hyperthermia 1 ; RYR1-related disorder ; Inborn genetic diseases	38,561,121(+)	NM_000540.3(RYR1):c.12291C>A (p.Asp4097Glu)	D4097E
Uncertain significance: Malignant Hyperthermia ; Malignant Hyperthermia 1 ; RYR1-related disorder	38,565,676(+)	NM_000540.3(RYR1):c.13342C>G (p.Pro4448Ala)	P4448A
Uncertain significance: RYR1-related disorder	38,440,784(+)	NM_000540.3(RYR1):c.85A>G (p.Lys29Glu)	K29E
Uncertain significance: Malignant Hyperthermia ; Malignant Hyperthermia 1 ; RYR1-related disorder ; not provided	38,458,068(+)	NM_000540.3(RYR1):c.1943T>C (p.Phe648Ser)	F648S
Uncertain significance: Malignant Hyperthermia ; Malignant Hyperthermia 1 ; RYR1-related disorder	38,485,970(+)	NM_000540.3(RYR1):c.5315G>C (p.Arg1772Thr)	R1772T
Uncertain significance: RYR1-related disorder ; not provided	38,523,227(+)	NM_000540.3(RYR1):c.10358G>A (p.Arg3453His)	R3453H
Uncertain significance: RYR1-related disorder ; not provided	38,565,427(+)	NM_000540.3(RYR1):c.13093G>T (p.Gly4365Cys)	G4365C
Likely benign: Congenital Myopathy 4A ; King-Denborough Syndrome ; Congenital Myopathy 1A ; Congenital Multicore Myopathy With External Ophthalmoplegia ; Congenital Myopathy 1A, Autosomal Dominant, With Malignant Hyperthermia ; Congenital Myopathy 4A, Autosomal Dominant ; Congenital Myopathy 1B, Autosomal Recessive ; Neuromuscular disease, congenital, with uniform type 1 fiber Benign/Likely benign: not provided ; Malignant hyperthermia 1 Benign: Malignant Hyperthermia ; Malignant Hyperthermia 1 ; not specified ; RYR1-related disorder	38,566,975(+)	NM_000540.3(RYR1):c.13502C>T (p.Pro4501Leu)	P4501L
Likely benign: not specified ; not provided ; RYR1-related disorder ; Inborn genetic diseases	38,572,119(+)	NM_000540.3(RYR1):c.13847C>A (p.Ala4616Asp)	A4616D
Likely benign: Neuromuscular disease, congenital, with uniform type 1 fiber ; not provided Benign/Likely benign: not specified Benign: Congenital Myopathy 1A ; Congenital Multicore Myopathy With External Ophthalmoplegia ; Malignant Hyperthermia ; Congenital Myopathy 1A, Autosomal Dominant, With Malignant Hyperthermia ; Congenital Myopathy 1B, Autosomal Recessive ; Malignant Hyperthermia 1 ; RYR1-related disorder	38,467,757(+)	NM_000540.3(RYR1):c.3326G>A (p.Arg1109Lys)	R1109K
Likely benign: RYR1-related disorder	38,565,556(+)	NM_000540.3(RYR1):c.13222G>C (p.Ala4408Pro)	A4408P
Likely benign: Congenital Myopathy 1A ; Congenital Multicore Myopathy With External Ophthalmoplegia ; Congenital Myopathy 1A, Autosomal Dominant, With Malignant Hyperthermia ; Congenital Myopathy 1B, Autosomal Recessive ; Neuromuscular disease, congenital, with uniform type 1 fiber Benign/Likely benign: Malignant Hyperthermia ; Malignant Hyperthermia 1 ; not specified ; not provided Benign: RYR1-related disorder	38,543,804(+)	NM_000540.3(RYR1):c.11941C>T (p.His3981Tyr)	H3976Y
Likely benign: RYR1-related disorder	38,473,637(+)	NM_000540.3(RYR1):c.4026C>A (p.Ser1342Arg)	S1342R
Likely benign: RYR1-related disorder	38,492,574(+)	NM_000540.3(RYR1):c.6212G>A (p.Arg2071Gln)	R2071Q
Likely benign: not provided Benign: Malignant Hyperthermia ; Malignant Hyperthermia 1 ; RYR1-related disorder	38,473,557(+)	NM_000540.3(RYR1):c.3946C>A (p.Pro1316Thr)	P1316T
Likely benign: Malignant Hyperthermia ; Malignant Hyperthermia 1 ; RYR1-related disorder	38,578,001(+)	NM_000540.3(RYR1):c.14256_14257delinsCA (p.Ala4753Thr)	A4753T
Likely benign: RYR1-related disorder	38,496,501(+)	NM_000540.3(RYR1):c.6756C>A (p.Asp2252Glu)	D2252E
Likely benign: Malignant Hyperthermia ; Malignant Hyperthermia 1 ; RYR1-related disorder	38,467,613(+)	NM_000540.3(RYR1):c.3182A>G (p.Gln1061Arg)	Q1061R
Likely benign: Malignant Hyperthermia ; Malignant Hyperthermia 1 ; RYR1-related disorder	38,452,892(+)	NM_000540.3(RYR1):c.1318G>A (p.Val440Ile)	V440I
Likely benign: RYR1-related disorder	38,561,353(+)	NM_000540.3(RYR1):c.12523C>G (p.Pro4175Ala)	P4175A
Likely benign: Congenital Myopathy 1A ; Malignant Hyperthermia ; Congenital Myopathy 1A, Autosomal Dominant, With Malignant Hyperthermia ; Congenital Myopathy 1B, Autosomal Recessive ; Neuromuscular disease, congenital, with uniform type 1 fiber Benign/Likely benign: not provided Benign: Malignant Hyperthermia 1 ; not specified ; RYR1-related disorder	38,528,602(+)	NM_000540.3(RYR1):c.10941C>G (p.His3647Gln)	H3642Q
Pathogenic: Cystic Fibrosis Likely pathogenic: Bronchiectasis With Or Without Elevated Sweat Chloride 1 ; CFTR-related disorder	117,535,248(+)	NM_000492.4(CFTR):c.580G>A (p.Gly194Arg)	G194R
Pathogenic: Cystic Fibrosis	117,559,594(+)	NM_000492.4(CFTR):c.1523T>G (p.Phe508Cys)	F508C
Pathogenic: Cystic Fibrosis	117,603,574(+)	NM_000492.4(CFTR):c.2700T>A (p.Asn900Lys)	N900K
Pathogenic: Pancreatitis, Hereditary Pathogenic/Likely pathogenic: Cystic fibrosis (CF)	117,534,318(+)	NM_000492.4(CFTR):c.532G>C (p.Gly178Arg)	G178R
Pathogenic: Pancreatitis, Hereditary Uncertain significance: not specified	117,590,355(+)	NM_000492.4(CFTR):c.1682C>T (p.Ala561Val)	A561V
Pathogenic: Cystic Fibrosis ; CFTR-related disorder	117,531,058(+)	NM_000492.4(CFTR):c.433C>G (p.Leu145Val)	L145V
Pathogenic: Cystic Fibrosis ; CFTR-related disorder	117,530,921(+)	NM_000492.4(CFTR):c.296C>G (p.Pro99Arg)	P99R
Pathogenic: Cystic Fibrosis Pathogenic/Likely pathogenic: Cystic fibrosis (CF)	117,590,353(+)	NM_000492.4(CFTR):c.1680A>T (p.Arg560Ser)	R560S
Pathogenic: Cystic Fibrosis	117,611,744(+)	NM_000492.4(CFTR):c.3303_3304delinsAG (p.Met1101_Arg1102delinsIleGly)	
Pathogenic: Cystic Fibrosis Pathogenic/Likely pathogenic: Congenital bilateral absence of the vas deferens ; Cystic fibrosis (CF)	117,530,975(+)	NM_000492.4(CFTR):c.350G>A (p.Arg117His)	R117H
Pathogenic: Cystic Fibrosis Uncertain significance: not specified	117,535,336(+)	NM_000492.4(CFTR):c.668C>T (p.Ala223Val)	A223V
Pathogenic: Cystic Fibrosis Uncertain significance: Congenital bilateral absence of the vas deferens ; Cystic fibrosis (CF)	117,603,730(+)	NM_000492.4(CFTR):c.2856G>T (p.Met952Ile)	M952I
Pathogenic: Vas Deferens, Congenital Bilateral Aplasia Of ; Bronchiectasis With Or Without Elevated Sweat Chloride 1 Likely pathogenic: CFTR-related disorder Conflicting interpretations of pathogenicity: Cystic Fibrosis ; not provided	117,611,738(+)	NM_000492.4(CFTR):c.3297C>A (p.Phe1099Leu)	F1099L
Pathogenic: Cystic Fibrosis Pathogenic/Likely pathogenic: Cystic fibrosis (CF)	117,540,163(+)	NM_000492.4(CFTR):c.933C>A (p.Phe311Leu)	F311L
Uncertain significance: Cystic Fibrosis	117,592,296(+)	NM_000492.4(CFTR):c.2129A>G (p.Lys710Arg)	K710R
Uncertain significance: Cystic Fibrosis	117,590,411(+)	NM_000492.4(CFTR):c.1738G>A (p.Val580Ile)	V580I
Uncertain significance: Cystic Fibrosis ; not specified	117,504,341(+)	NM_000492.4(CFTR):c.142A>C (p.Asn48His)	N48H
Uncertain significance: Cystic Fibrosis	117,611,619(+)	NM_000492.4(CFTR):c.3178A>G (p.Lys1060Glu)	K1060E
Uncertain significance: Cystic Fibrosis	117,536,558(+)	NM_000492.4(CFTR):c.754G>A (p.Ala252Thr)	A252T
Uncertain significance: Cystic Fibrosis	117,531,028(+)	NM_000492.4(CFTR):c.403A>T (p.Thr135Ser)	T135S
Uncertain significance: Cystic Fibrosis	117,530,938(+)	NM_000492.4(CFTR):c.313A>C (p.Ile105Leu)	I105L
Uncertain significance: Cystic Fibrosis ; not specified	117,594,970(+)	NM_000492.4(CFTR):c.2531C>T (p.Thr844Ile)	T844I
Uncertain significance: Cystic Fibrosis	117,480,123(+)	NM_000492.4(CFTR):c.29G>C (p.Ser10Thr)	S10T
Uncertain significance: Cystic Fibrosis	117,559,606(+)	NM_000492.4(CFTR):c.1535A>G (p.Tyr512Cys)	Y512C
Uncertain significance: Cystic Fibrosis ; not specified	117,627,582(+)	NM_000492.4(CFTR):c.3529A>G (p.Lys1177Glu)	K1177E
Uncertain significance: Cystic Fibrosis ; Vas Deferens, Congenital Bilateral Aplasia Of ; Pancreatitis, Hereditary ; Bronchiectasis With Or Without Elevated Sweat Chloride 1	117,592,280(+)	NM_000492.4(CFTR):c.2113A>G (p.Ile705Val)	I705V
Uncertain significance: Cystic Fibrosis	117,548,714(+)	NM_000492.4(CFTR):c.1283T>A (p.Leu428His)	L428H
Uncertain significance: Cystic Fibrosis	117,594,934(+)	NM_000492.4(CFTR):c.2495G>A (p.Cys832Tyr)	C832Y
Uncertain significance: Cystic Fibrosis	117,530,905(+)	NM_000492.4(CFTR):c.280A>C (p.Thr94Pro)	T94P
Uncertain significance: Cystic Fibrosis	117,509,126(+)	NM_000492.4(CFTR):c.257T>A (p.Ile86Asn)	I86N
Uncertain significance: Cystic Fibrosis	117,592,372(+)	NM_000492.4(CFTR):c.2205G>C (p.Arg735Ser)	R735S
Uncertain significance: Cystic Fibrosis	117,665,500(+)	NM_000492.4(CFTR):c.4178C>G (p.Ala1393Gly)	A1393G
Uncertain significance: Cystic Fibrosis	117,667,092(+)	NM_000492.4(CFTR):c.4427A>G (p.Gln1476Arg)	Q1476R
Uncertain significance: Cystic Fibrosis	117,603,705(+)	NM_000492.4(CFTR):c.2831T>C (p.Val944Ala)	V944A
Uncertain significance: Cystic Fibrosis ; not specified	117,531,002(+)	NM_000492.4(CFTR):c.377G>C (p.Gly126Ala)	G126A
Uncertain significance: Cystic Fibrosis	117,592,454(+)	NM_000492.4(CFTR):c.2287G>A (p.Ala763Thr)	A763T
Uncertain significance: Cystic Fibrosis	117,542,088(+)	NM_000492.4(CFTR):c.1189G>C (p.Val397Leu)	V397L
Uncertain significance: Cystic Fibrosis	117,594,942(+)	NM_000492.4(CFTR):c.2503G>A (p.Asp835Asn)	D835N
Uncertain significance: Cystic Fibrosis ; not specified	117,627,615(+)	NM_000492.4(CFTR):c.3562T>C (p.Ser1188Pro)	S1188P
Uncertain significance: Cystic Fibrosis	117,548,771(+)	NM_000492.4(CFTR):c.1340A>G (p.Lys447Arg)	K447R
Uncertain significance: Cystic Fibrosis	117,548,730(+)	NM_000492.4(CFTR):c.1299C>A (p.Phe433Leu)	F433L
Uncertain significance: Cystic Fibrosis ; CFTR-related disorder	117,603,734(+)	NM_000492.4(CFTR):c.2860C>T (p.His954Tyr)	H954Y
Uncertain significance: Cystic Fibrosis	117,627,729(+)	NM_000492.4(CFTR):c.3676A>G (p.Ile1226Val)	I1226V
Uncertain significance: Cystic Fibrosis	117,536,642(+)	NM_000492.4(CFTR):c.838G>T (p.Ala280Ser)	A280S
Uncertain significance: Cystic Fibrosis	117,603,579(+)	NM_000492.4(CFTR):c.2705G>C (p.Ser902Thr)	S902T
Uncertain significance: Cystic Fibrosis	117,504,303(+)	NM_000492.4(CFTR):c.104C>T (p.Ser35Leu)	S35L
Uncertain significance: Cystic Fibrosis	117,534,284(+)	NM_000492.4(CFTR):c.498G>C (p.Lys166Asn)	K166N
Uncertain significance: Cystic Fibrosis	117,480,143(+)	NM_000492.4(CFTR):c.49T>C (p.Phe17Leu)	F17L
Uncertain significance: Cystic Fibrosis	117,627,541(+)	NM_000492.4(CFTR):c.3488T>G (p.Val1163Gly)	V1163G
Likely benign: not provided Benign/Likely benign: Cystic Fibrosis	117,559,590(+)	NM_000492.4(CFTR):c.1519A>G (p.Ile507Val)	I507V
Likely benign: Cystic Fibrosis	117,595,044(+)	NM_000492.4(CFTR):c.2605A>G (p.Ile869Val)	I869V
Likely benign: Cystic Fibrosis	117,610,555(+)	NM_000492.4(CFTR):c.3025G>T (p.Ala1009Ser)	A1009S
Likely benign: Cystic Fibrosis	117,667,049(+)	NM_000492.4(CFTR):c.4384C>T (p.Pro1462Ser)	P1462S
Likely benign: Cystic Fibrosis	117,592,434(+)	NM_000492.4(CFTR):c.2267G>A (p.Ser756Asn)	S756N
Likely benign: Cystic Fibrosis	117,548,681(+)	NM_000492.4(CFTR):c.1250A>G (p.Asn417Ser)	N417S
Likely benign: Cystic Fibrosis	117,603,665(+)	NM_000492.4(CFTR):c.2791T>C (p.Phe931Leu)	F931L
Likely benign: Cystic Fibrosis	117,592,448(+)	NM_000492.4(CFTR):c.2281C>T (p.Leu761Phe)	L761F
Likely benign: Cystic Fibrosis	117,667,052(+)	NM_000492.4(CFTR):c.4387C>A (p.Gln1463Lys)	Q1463K
Likely benign: CFTR-related disorder Benign/Likely benign: not specified ; not provided Benign: Cystic Fibrosis	117,559,479(+)	NM_000492.4(CFTR):c.1408G>A (p.Val470Met)	V470M
Pathogenic: Walker-Warburg Syndrome	46,755,451(+)	NM_024301.5(FKRP):c.1A>C (p.Met1Leu)	M1L
Pathogenic: Walker-Warburg Syndrome Likely pathogenic: Abnormality of the musculature	46,756,462(+)	NM_024301.5(FKRP):c.1012G>C (p.Val338Leu)	V338L
Pathogenic: Muscular Dystrophy-Dystroglycanopathy , Type A, 5 ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 ; not provided	46,755,451(+)	NM_024301.5(FKRP):c.1A>G (p.Met1Val)	M1V
Pathogenic: Walker-Warburg Syndrome	46,755,601(+)	NM_024301.5(FKRP):c.151G>T (p.Val51Phe)	V51F
Pathogenic: Walker-Warburg Syndrome Uncertain significance: Muscular Dystrophy-Dystroglycanopathy , Type C, 5 ; Cardiovascular phenotype ; not specified	46,756,096(+)	NM_024301.5(FKRP):c.646C>T (p.Arg216Trp)	R216W
Pathogenic: Walker-Warburg Syndrome	46,756,327(+)	NM_024301.5(FKRP):c.877A>G (p.Thr293Ala)	T293A
Pathogenic: Walker-Warburg Syndrome ; Muscular Dystrophy-Dystroglycanopathy , Type A, 5 ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 Pathogenic/Likely pathogenic: Muscular Dystrophy-Dystroglycanopathy , Type B, 5 ; Muscular Dystrophy-Dystroglycanopathy , Type C, 5 ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 Likely pathogenic: Autosomal Recessive Limb-Girdle Muscular Dystrophy ; FKRP-related disorder Uncertain significance: Muscular Dystrophy-Dystroglycanopathy , Type A, 1 ; not provided ; Cardiovascular phenotype ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 ; Muscular dystrophy-dystroglycanopathy limb-girdle C5	46,756,523(+)	NM_024301.5(FKRP):c.1073C>T (p.Pro358Leu)	P358L
Pathogenic: Autosomal Recessive Limb-Girdle Muscular Dystrophy Uncertain significance: Cardiovascular phenotype	46,755,779(+)	NM_024301.5(FKRP):c.329G>C (p.Arg110Pro)	R110P
Pathogenic: Walker-Warburg Syndrome	46,756,550(+)	NM_024301.5(FKRP):c.1100T>A (p.Ile367Asn)	I367N
Pathogenic: Walker-Warburg Syndrome	46,756,435(+)	NM_024301.5(FKRP):c.985G>A (p.Val329Met)	V329M
Pathogenic: Walker-Warburg Syndrome ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 Pathogenic/Likely pathogenic: Muscular dystrophy-dystroglycanopathy congenital with or without impaired intellectual development B5 ; Muscular dystrophy-dystroglycanopathy limb-girdle C5 Likely pathogenic: Muscular Dystrophy-Dystroglycanopathy , Type A, 5 ; Muscular Dystrophy-Dystroglycanopathy , Type A, 1 ; Muscular Dystrophy-Dystroglycanopathy , Type B, 5 ; Muscular Dystrophy-Dystroglycanopathy , Type C, 5 ; not provided ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5	46,756,397(+)	NM_024301.5(FKRP):c.947C>G (p.Pro316Arg)	P316R
Pathogenic: Walker-Warburg Syndrome ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 Likely pathogenic: Autosomal Recessive Limb-Girdle Muscular Dystrophy ; Cardiovascular phenotype Conflicting interpretations of pathogenicity: Muscular Dystrophy-Dystroglycanopathy , Type C, 5 ; not provided ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 Uncertain significance: Muscular Dystrophy-Dystroglycanopathy , Type A, 5 ; Muscular Dystrophy-Dystroglycanopathy , Type A, 1 ; Muscular Dystrophy-Dystroglycanopathy , Type B, 5 ; not specified ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 ; Muscular dystrophy-dystroglycanopathy limb-girdle C5	46,756,348(+)	NM_024301.5(FKRP):c.898G>A (p.Val300Met)	V300M
Pathogenic: Muscular Dystrophy-Dystroglycanopathy , Type A, 5 ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 Likely pathogenic: Autosomal Recessive Limb-Girdle Muscular Dystrophy Uncertain significance: Walker-Warburg Syndrome	46,755,919(+)	NM_024301.5(FKRP):c.469G>C (p.Ala157Pro)	A157P
Pathogenic: Muscular Dystrophy-Dystroglycanopathy , Type A, 5 ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 Likely pathogenic: Muscular Dystrophy-Dystroglycanopathy , Type B, 5 ; Muscular Dystrophy-Dystroglycanopathy , Type C, 5 ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 Uncertain significance: not specified	46,756,660(+)	NM_024301.5(FKRP):c.1210C>T (p.Arg404Cys)	R404C
Uncertain significance: Walker-Warburg Syndrome ; Muscular Dystrophy-Dystroglycanopathy , Type C, 5	46,756,247(+)	NM_024301.5(FKRP):c.797C>T (p.Ala266Val)	A266V
Uncertain significance: Walker-Warburg Syndrome ; Muscular Dystrophy-Dystroglycanopathy , Type C, 5 ; Cardiovascular phenotype	46,755,755(+)	NM_024301.5(FKRP):c.305C>A (p.Ala102Glu)	A102E
Uncertain significance: Walker-Warburg Syndrome ; Cardiovascular phenotype	46,755,554(+)	NM_024301.5(FKRP):c.104G>A (p.Arg35Gln)	R35Q
Uncertain significance: Walker-Warburg Syndrome ; Muscular Dystrophy-Dystroglycanopathy , Type A, 5 ; Muscular Dystrophy-Dystroglycanopathy , Type A, 1 ; Muscular Dystrophy-Dystroglycanopathy , Type B, 5 ; Muscular Dystrophy-Dystroglycanopathy , Type C, 5 ; Cardiovascular phenotype ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5	46,756,642(+)	NM_024301.5(FKRP):c.1192G>A (p.Val398Ile)	V398I
Uncertain significance: Walker-Warburg Syndrome	46,756,138(+)	NM_024301.5(FKRP):c.688G>A (p.Gly230Ser)	G230S
Uncertain significance: Walker-Warburg Syndrome ; Cardiovascular phenotype	46,755,724(+)	NM_024301.5(FKRP):c.274G>T (p.Ala92Ser)	A92S
Uncertain significance: Walker-Warburg Syndrome	46,756,033(+)	NM_024301.5(FKRP):c.583G>T (p.Asp195Tyr)	D195Y
Uncertain significance: Walker-Warburg Syndrome	46,756,821(+)	NM_024301.5(FKRP):c.1371C>G (p.Phe457Leu)	F457L
Uncertain significance: Walker-Warburg Syndrome	46,755,986(+)	NM_024301.5(FKRP):c.536C>A (p.Thr179Asn)	T179N
Uncertain significance: Walker-Warburg Syndrome	46,756,760(+)	NM_024301.5(FKRP):c.1310A>G (p.Gln437Arg)	Q437R
Uncertain significance: Walker-Warburg Syndrome	46,756,340(+)	NM_024301.5(FKRP):c.890T>G (p.Phe297Cys)	F297C
Uncertain significance: Walker-Warburg Syndrome	46,756,568(+)	NM_024301.5(FKRP):c.1118G>A (p.Gly373Asp)	G373D
Uncertain significance: Walker-Warburg Syndrome	46,756,610(+)	NM_024301.5(FKRP):c.1160T>C (p.Val387Ala)	V387A
Uncertain significance: Walker-Warburg Syndrome	46,756,810(+)	NM_024301.5(FKRP):c.1360T>C (p.Phe454Leu)	F454L
Uncertain significance: Walker-Warburg Syndrome ; not provided ; Cardiovascular phenotype	46,755,733(+)	NM_024301.5(FKRP):c.283C>T (p.Arg95Cys)	R95C
Uncertain significance: Muscular Dystrophy-Dystroglycanopathy , Type C, 5	46,756,580(+)	NM_024301.5(FKRP):c.1130A>G (p.Gln377Arg)	Q377R
Uncertain significance: not provided	46,755,932(+)	NM_024301.5(FKRP):c.482C>T (p.Ala161Val)	A161V
Uncertain significance: Muscular Dystrophy-Dystroglycanopathy , Type A, 5 ; Muscular Dystrophy-Dystroglycanopathy , Type B, 5 ; Muscular Dystrophy-Dystroglycanopathy , Type C, 5 ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5	46,755,569(+)	NM_024301.5(FKRP):c.119G>A (p.Arg40His)	R40H
Uncertain significance: not provided Benign: Walker-Warburg Syndrome	46,756,477(+)	NM_024301.5(FKRP):c.1027G>C (p.Glu343Gln)	E343Q
Uncertain significance: Muscular Dystrophy-Dystroglycanopathy , Type A, 5 ; Muscular Dystrophy-Dystroglycanopathy , Type B, 5 ; Muscular Dystrophy-Dystroglycanopathy , Type C, 5 ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 Likely benign: Walker-Warburg Syndrome ; not provided Benign/Likely benign: not specified Benign: Cardiovascular phenotype	46,756,272(+)	NM_024301.5(FKRP):c.822C>G (p.Ile274Met)	I274M
Likely benign: Muscular Dystrophy-Dystroglycanopathy , Type A, 5 ; Muscular Dystrophy-Dystroglycanopathy , Type A, 1 ; Muscular Dystrophy-Dystroglycanopathy , Type B, 5 ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 Benign/Likely benign: not specified Benign: Walker-Warburg Syndrome ; Hypertrophic Cardiomyopathy ; Muscular Dystrophy-Dystroglycanopathy , Type C, 5 ; Cardiomyopathy ; not provided ; Cardiovascular phenotype	46,755,970(+)	NM_024301.5(FKRP):c.520A>T (p.Ser174Cys)	S174C
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy Likely pathogenic: not provided	165,992,255(-)	NM_001165963.4(SCN1A):c.5020G>A (p.Gly1674Ser)	G1674S
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,012,126(-)	NM_001165963.4(SCN1A):c.3862G>A (p.Asp1288Asn)	D1288N
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	165,994,322(-)	NM_001165963.4(SCN1A):c.4676T>G (p.Met1559Arg)	M1559R
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy Likely pathogenic: Dravet Syndrome ; not provided	166,048,928(-)	NM_001165963.4(SCN1A):c.986G>C (p.Gly329Ala)	G329A
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	165,991,840(-)	NM_001165963.4(SCN1A):c.5435G>C (p.Trp1812Ser)	W1812S
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; Seizure Likely pathogenic: Generalized Epilepsy With Febrile Seizures Plus, Type 2 ; Dravet Syndrome	165,991,694(-)	NM_001165963.4(SCN1A):c.5581C>T (p.Arg1861Trp)	R1861W
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,046,948(-)	NM_001165963.4(SCN1A):c.1199T>C (p.Met400Thr)	M400T
Pathogenic: Developmental And Epileptic Encephalopathy 6B ; Migraine, Familial Hemiplegic, 3 ; Generalized Epilepsy With Febrile Seizures Plus, Type 2 ; Dravet Syndrome Likely pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,047,628(-)	NM_001165963.4(SCN1A):c.1169T>C (p.Leu390Pro)	L390P
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	165,991,951(-)	NM_001165963.4(SCN1A):c.5324T>C (p.Leu1775Pro)	L1775P
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,051,817(-)	NM_001165963.4(SCN1A):c.866A>T (p.Glu289Val)	E289V
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy Pathogenic/Likely pathogenic: Dravet syndrome	166,047,648(-)	NM_001165963.4(SCN1A):c.1149C>A (p.Phe383Leu)	F383L
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,013,789(-)	NM_001165963.4(SCN1A):c.3660T>G (p.Phe1220Leu)	F1220L
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy Likely pathogenic: Neurodevelopmental disorder	166,009,744(-)	NM_001165963.4(SCN1A):c.3977C>A (p.Ala1326Asp)	A1326D
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy Likely pathogenic: Dravet Syndrome	166,047,679(-)	NM_001165963.4(SCN1A):c.1118T>C (p.Leu373Ser)	L373S
Pathogenic: not provided Likely pathogenic: Epilepsy Uncertain significance: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,046,853(-)	NM_001165963.4(SCN1A):c.1294G>C (p.Ala432Pro)	A432P
Pathogenic: Generalized Epilepsy With Febrile Seizures Plus, Type 2	165,992,155(-)	NM_001165963.4(SCN1A):c.5120T>C (p.Phe1707Ser)	F1707S
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	165,992,096(-)	NM_001165963.4(SCN1A):c.5179G>C (p.Asp1727His)	D1727H
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	165,996,039(-)	NM_001165963.4(SCN1A):c.4555C>T (p.Pro1519Ser)	P1519S
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,073,450(-)	NM_001165963.4(SCN1A):c.172G>A (p.Gly58Arg)	G58R
Pathogenic: Generalized Epilepsy With Febrile Seizures Plus, Type 2 Likely pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	165,991,506(-)	NM_001165963.4(SCN1A):c.5769G>C (p.Gln1923His)	Q1923H
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,073,379(-)	NM_001165963.4(SCN1A):c.243C>A (p.Asp81Glu)	D81E
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,002,473(-)	NM_001165963.4(SCN1A):c.4283T>A (p.Val1428Asp)	V1428D
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,037,860(-)	NM_001165963.4(SCN1A):c.2862G>C (p.Glu954Asp)	E954D
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy Likely pathogenic: Dravet Syndrome	166,051,871(-)	NM_001165963.4(SCN1A):c.812G>T (p.Gly271Val)	G271V
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	165,992,227(-)	NM_001165963.4(SCN1A):c.5048T>C (p.Ile1683Thr)	I1683T
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy Likely pathogenic: Inborn genetic diseases	165,994,151(-)	NM_001165963.4(SCN1A):c.4847T>C (p.Ile1616Thr)	I1616T
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy Likely pathogenic: Dravet Syndrome	165,994,397(-)	NM_001165963.4(SCN1A):c.4601T>A (p.Val1534Asp)	V1534D
Uncertain significance: Developmental And Epileptic Encephalopathy 6B	166,045,237(-)	NM_001165963.4(SCN1A):c.1468A>C (p.Ser490Arg)	S490R
Uncertain significance: Developmental And Epileptic Encephalopathy 6B	166,044,012(-)	NM_001165963.4(SCN1A):c.1700G>C (p.Arg567Thr)	R567T
Uncertain significance: not provided	165,991,886(-)	NM_001165963.4(SCN1A):c.5389G>A (p.Ala1797Thr)	A1797T
Uncertain significance: not provided	166,015,649(-)	NM_001165963.4(SCN1A):c.3508G>A (p.Glu1170Lys)	E1170K
Uncertain significance: not provided	166,036,073(-)	NM_001165963.4(SCN1A):c.3404A>G (p.Glu1135Gly)	E1135G
Uncertain significance: Generalized Epilepsy With Febrile Seizures Plus, Type 2	165,991,921(-)	NM_001165963.4(SCN1A):c.5354T>C (p.Ile1785Thr)	I1785T
Uncertain significance: Dravet Syndrome ; not provided	166,054,690(-)	NM_001165963.4(SCN1A):c.550A>T (p.Thr184Ser)	T184S
Uncertain significance: Generalized Epilepsy With Febrile Seizures Plus, Type 2	166,037,883(-)	NM_001165963.4(SCN1A):c.2839G>C (p.Val947Leu)	V947L
Uncertain significance: not provided ; Inborn genetic diseases	166,054,686(-)	NM_001165963.4(SCN1A):c.554T>C (p.Phe185Ser)	F185S
Uncertain significance: not provided	166,054,765(-)	NM_001165963.4(SCN1A):c.475T>C (p.Tyr159His)	Y159H
Uncertain significance: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,041,416(-)	NM_001165963.4(SCN1A):c.2230A>G (p.Ile744Val)	I744V
Uncertain significance: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; not provided	166,037,938(-)	NM_001165963.4(SCN1A):c.2784A>C (p.Gln928His)	Q928H
Uncertain significance: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; not provided	165,992,039(-)	NM_001165963.4(SCN1A):c.5236G>C (p.Val1746Leu)	V1746L
Uncertain significance: Inborn genetic diseases Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,051,776(-)	NM_001165963.4(SCN1A):c.907A>T (p.Thr303Ser)	T303S
Uncertain significance: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,046,952(-)	NM_001165963.4(SCN1A):c.1195T>C (p.Tyr399His)	Y399H
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; Inborn genetic diseases	166,013,865(-)	NM_001165963.4(SCN1A):c.3584A>G (p.Asn1195Ser)	N1195S
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,051,791(-)	NM_001165963.4(SCN1A):c.892G>A (p.Val298Met)	V298M
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,051,788(-)	NM_001165963.4(SCN1A):c.895A>G (p.Asn299Asp)	N299D
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,015,651(-)	NM_001165963.4(SCN1A):c.3506T>G (p.Val1169Gly)	V1169G
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,039,461(-)	NM_001165963.4(SCN1A):c.2551A>G (p.Asn851Asp)	N851D
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,043,727(-)	NM_001165963.4(SCN1A):c.1985C>T (p.Ser662Leu)	S662L
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,045,315(-)	NM_001165963.4(SCN1A):c.1390G>C (p.Ala464Pro)	A464P
Likely benign: Nervous System Disease ; Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; Congenital Nervous System Abnormality ; not provided ; Global developmental delay ; Atypical behavior ; Aggressive behavior ; Gait disturbance ; Intellectual disability ; Impulsivity ; Inborn genetic diseases ; SCN1A-related disorder	166,037,952(-)	NM_001165963.4(SCN1A):c.2770G>A (p.Ala924Thr)	A924T
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; not provided	166,041,268(-)	NM_001165963.4(SCN1A):c.2378C>T (p.Thr793Met)	T793M
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; not provided ; Inborn genetic diseases Benign: not specified	166,073,554(-)	NM_001165963.4(SCN1A):c.68C>T (p.Ala23Val)	A23V
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; not provided ; not specified	166,042,390(-)	NM_001165963.4(SCN1A):c.2078G>T (p.Arg693Met)	R693M
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	166,045,155(-)	NM_001165963.4(SCN1A):c.1550A>G (p.Glu517Gly)	E517G
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy Likely pathogenic: Developmental And Epileptic Encephalopathy 7	63,413,493(-)	NM_172107.4(KCNQ2):c.1720G>A (p.Gly574Ser)	G574S
Pathogenic: not provided Likely pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	63,439,608(-)	NM_172107.4(KCNQ2):c.917C>A (p.Ala306Glu)	A306E
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; not provided	63,433,807(-)	NM_172107.4(KCNQ2):c.1118+2T>G	Y374D
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	63,433,863(-)	NM_172107.4(KCNQ2):c.1064A>G (p.Asp355Gly)	D355G
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	63,442,488(-)	NM_172107.4(KCNQ2):c.734T>C (p.Leu245Pro)	L245P
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	63,433,870(-)	NM_172107.4(KCNQ2):c.1056_1057delinsCG (p.Arg353Gly)	R353G
Pathogenic: Developmental And Epileptic Encephalopathy 7	63,439,647(-)	NM_172107.4(KCNQ2):c.878T>C (p.Leu293Pro)	L293P
Pathogenic: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; Kcnq2-Related Disorders ; not provided ; Intellectual disability ; Seizure Pathogenic/Likely pathogenic: Developmental And Epileptic Encephalopathy 7 Likely pathogenic: Seizures, Benign Familial Neonatal, 1 ; Inborn genetic diseases	63,442,428(-)	NM_172107.4(KCNQ2):c.794C>T (p.Ala265Val)	A265V
Pathogenic: Kcnq2-Related Disorders Pathogenic/Likely pathogenic: Developmental and epileptic encephalopathy 7	63,413,532(-)	NM_172107.4(KCNQ2):c.1681C>T (p.Pro561Ser)	P561S
Pathogenic: not provided Not provided: Kcnq2-Related Disorders	63,445,270(-)	NM_172107.4(KCNQ2):c.482T>C (p.Leu161Pro)	L161P
Uncertain significance: not provided	63,413,524(-)	NM_172107.4(KCNQ2):c.1688_1689delinsCA (p.Asp563Ala)	D563A
Uncertain significance: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; not provided	63,445,295(-)	NM_172107.4(KCNQ2):c.457C>T (p.Arg153Trp)	R153W
Uncertain significance: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy 7 ; Seizures, Benign Familial Neonatal, 1 ; Developmental And Epileptic Encephalopathy ; not provided	63,414,160(-)	NM_172107.4(KCNQ2):c.1559A>G (p.Asp520Gly)	D520G
Uncertain significance: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	63,445,355(-)	NM_172107.4(KCNQ2):c.397A>G (p.Thr133Ala)	T133A
Uncertain significance: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	63,406,655(-)	NM_172107.4(KCNQ2):c.2608C>T (p.Pro870Ser)	P870S
Uncertain significance: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	63,428,424(-)	NM_172107.4(KCNQ2):c.1160C>A (p.Pro387Gln)	P387Q
Uncertain significance: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	63,414,969(-)	NM_172107.4(KCNQ2):c.1459G>C (p.Gly487Arg)	G487R
Uncertain significance: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	63,428,397(-)	NM_172107.4(KCNQ2):c.1187A>G (p.Asn396Ser)	N396S
Uncertain significance: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; not provided	63,442,461(-)	NM_172107.4(KCNQ2):c.761A>G (p.Glu254Gly)	E254G
Uncertain significance: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; Inborn genetic diseases	63,406,670(-)	NM_172107.4(KCNQ2):c.2593G>A (p.Val865Met)	V865M
Uncertain significance: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	63,415,061(-)	NM_172107.4(KCNQ2):c.1367G>A (p.Gly456Glu)	G456E
Uncertain significance: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy	63,445,259(-)	NM_172107.4(KCNQ2):c.493C>T (p.Arg165Trp)	R165W
Likely benign: not specified	63,433,756(-)	NM_172107.4(KCNQ2):c.1118+53A>G	I391V
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; Inborn genetic diseases Benign/Likely benign: not provided	63,408,468(-)	NM_172107.4(KCNQ2):c.1832C>T (p.Ala611Val)	A611V
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; Kcnq2-Related Disorders ; Inborn genetic diseases Benign/Likely benign: not provided Not provided: Complex Neurodevelopmental Disorder	63,406,997(-)	NM_172107.4(KCNQ2):c.2266G>A (p.Gly756Ser)	G756S
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; not provided ; Inborn genetic diseases	63,406,933(-)	NM_172107.4(KCNQ2):c.2330C>G (p.Pro777Arg)	P777R
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; not specified ; Inborn genetic diseases	63,472,279(-)	NM_172107.4(KCNQ2):c.185C>T (p.Ala62Val)	A62V
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; not specified ; not provided ; Inborn genetic diseases Benign: Kcnq2-Related Disorders	63,419,667(-)	NM_172107.4(KCNQ2):c.1253G>T (p.Gly418Val)	G418V
Likely benign: Autism Spectrum Disorder	63,428,395(-)	NM_172107.4(KCNQ2):c.1189C>T (p.Leu397Phe)	L397F
Likely benign: Autism Spectrum Disorder	63,472,352(-)	NM_172107.4(KCNQ2):c.112G>C (p.Gly38Arg)	G38R
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; not provided ; Inborn genetic diseases	63,406,886(-)	NM_172107.4(KCNQ2):c.2377G>T (p.Val793Leu)	V793L
Likely benign: Developmental And Epileptic Encephalopathy 7 ; Seizures, Benign Familial Neonatal, 1 Benign: Kcnq2-Related Disorders	63,433,763(-)	NM_172107.4(KCNQ2):c.1118+46A>T	L388F
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; not specified	63,433,798(-)	NM_172107.4(KCNQ2):c.1118+11C>T	R377W
Likely benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; not specified	63,433,801(-)	NM_172107.4(KCNQ2):c.1118+8C>T	R376C
Benign/Likely benign: not specified Benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; not provided ; Inborn genetic diseases Not provided: Complex Neurodevelopmental Disorder	63,406,999(-)	NM_172107.4(KCNQ2):c.2264A>G (p.Tyr755Cys)	Y755C
Benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy ; not specified ; Inborn genetic diseases ; not provided	63,407,198(-)	NM_172107.4(KCNQ2):c.2065A>C (p.Ile689Leu)	I689L
Benign: Early Infantile Epileptic Encephalopathy ; Developmental And Epileptic Encephalopathy 7 ; Seizures, Benign Familial Neonatal, 1 ; Developmental And Epileptic Encephalopathy ; not specified ; not provided ; Inborn genetic diseases Not provided: Complex Neurodevelopmental Disorder	63,406,924(-)	NM_172107.4(KCNQ2):c.2339A>C (p.Asn780Thr)	N780T